Form 4: BioLife Solutions CEO Reports Tax-Related Share Disposition
Insider Transaction Report
BioLife Solutions President and CEO Roderick de Greef reported a disposition of 11,101 common shares to cover tax withholding obligations related to restricted stock unit release.
Summary
- Roderick de Greef, President and CEO of BioLife Solutions Inc. (BLFS), reported a transaction on March 19, 2026.
- The transaction involved the disposition of 11,101 shares of common stock.
- These shares were withheld by BioLife Solutions to satisfy tax withholding obligations arising from the release of restricted stock units.
- The shares were valued at $19.12 per share for the purpose of tax withholding.
- Following this transaction, Roderick de Greef directly beneficially owns 733,746 shares of BioLife Solutions common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. It is a standard, non-discretionary transaction related to executive compensation and tax obligations, not indicative of a change in company fundamentals or insider sentiment.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that insider transactions, particularly those related to tax withholdings from equity compensation, are common occurrences across all industries, especially for executives in publicly traded companies. This specific transaction does not indicate a shift in industry trends or competitive landscape.
Stakeholder Impact
- Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes, not a discretionary sale indicating lack of confidence.
Key Dates
| Date | Description |
|---|---|
| 03/19/2026 | Date of transaction (disposition of shares for tax withholding). |
| 03/23/2026 | Date Form 4 was signed and filed. |
Recommendation
holdThis Form 4 reports a routine, non-discretionary disposition of shares by the CEO to cover tax obligations upon the vesting of restricted stock units. It does not reflect a discretionary sale based on insider sentiment or a change in the company's fundamentals. Therefore, it provides no new information to alter an existing investment thesis, warranting a 'hold' recommendation based solely on this filing.
Keywords
BioLife Solutions, BLFS, Roderick de Greef, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units, CEO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.